Ma D - Search Results

1

Tanshinone IIA promotes vascular normalization and boosts Sorafenib's anti-hepatoma activity via modulating the PI3K-AKT pathway.

Qin C, Liu S, Zhou S, Xia X, Hu J, Yu Y, Ma D. Qin C, et al. Among authors: ma d. Front Pharmacol. 2023 Jun 1;14:1189532. doi: 10.3389/fphar.2023.1189532. eCollection 2023. Front Pharmacol. 2023. PMID: 37324455 Free PMC article.

2

PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.

Qin C, Liu S, Zhou S, Wang Q, Xia X, Hu J, Yuan X, Wang Z, Yu Y, Ma D. Qin C, et al. Among authors: ma d. Front Immunol. 2023 Mar 30;14:1114572. doi: 10.3389/fimmu.2023.1114572. eCollection 2023. Front Immunol. 2023. PMID: 37063922 Free PMC article.

3

The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study.

Zheng P, Xu G, Qin Z, Zhou S, Huang H, Ma D, Gao X. Zheng P, et al. Among authors: ma d. Surgery. 2024 Aug;176(2):310-318. doi: 10.1016/j.surg.2024.03.043. Epub 2024 May 16. Surgery. 2024. PMID: 38760234

4

Computational Dissection of the Role of Trp305 in the Regulation of the Death-Associated Protein Kinase-Calmodulin Interaction.

Zhu YP, Gao XY, Xu GH, Qin ZF, Ju HX, Li DC, Ma DN. Zhu YP, et al. Biomolecules. 2022 Sep 29;12(10):1395. doi: 10.3390/biom12101395. Biomolecules. 2022. PMID: 36291604 Free PMC article.

5

Negative prognostic impact of tumor deposits in stage III colorectal cancer patients.

Ma T, Qin Z, Xu G, Zheng PW, Feng L, Ma D, Fu Z, Gao X. Ma T, et al. Among authors: ma d. PLoS One. 2024 Sep 26;19(9):e0310327. doi: 10.1371/journal.pone.0310327. eCollection 2024. PLoS One. 2024. PMID: 39325798 Free PMC article.

6

Public Health.

Li L, Gurcan MN, Luo S, Ma D. Li L, et al. Among authors: ma d. Alzheimers Dement. 2024 Dec;20 Suppl 7:e089059. doi: 10.1002/alz.089059. Alzheimers Dement. 2024. PMID: 39784810

7

Biomarkers.

Ma D, Kyriacou S. Ma D, et al. Alzheimers Dement. 2024 Dec;20 Suppl 2:e092003. doi: 10.1002/alz.092003. Alzheimers Dement. 2024. PMID: 39784042

8

Biomarkers.

Ma D, Lockhart SN, Hughes TM, Bateman JR, Register TC, Mielke MM, Gurcan MN, Craft S. Ma D, et al. Alzheimers Dement. 2024 Dec;20 Suppl 2:e092668. doi: 10.1002/alz.092668. Alzheimers Dement. 2024. PMID: 39783867

9

Developing Topics.

Tavakoli F, Ma D, Ge Y. Tavakoli F, et al. Among authors: ma d. Alzheimers Dement. 2024 Dec;20 Suppl 8:e095769. doi: 10.1002/alz.095769. Alzheimers Dement. 2024. PMID: 39783212

10

Alzheimer's Imaging Consortium.

Ma D, Lockhart SN, Hughes TM, Bateman JR, Register TC, Mielke MM, Gurcan MN, Craft S. Ma D, et al. Alzheimers Dement. 2024 Dec;20 Suppl 9:e094074. doi: 10.1002/alz.094074. Alzheimers Dement. 2024. PMID: 39782859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,762 results

Search Page

Filters